WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 20'2901 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 26'6801 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 11'184  11'218  11'265  11'321  11'378  11'142  10'249  9'635 
Births 91  94  97  101  105  110  110  150 
Surviving infants 91  94  97  101  104  110  109  148 
Pop. less than 5 years 474  504  524  551  576  552  571  754 
Pop. less than 15 years 1'604  1'632  1'648  1'670  1'693  1'721  2'025  2'276 
Female 15-49 years 2'496  2'526  2'569  2'611  2'650  2'796  2'443  2'316 

Number of reported cases

(Click for retrospective incidence data for Greece)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  56  245  13'464 
Mumps
ChartChart
  32 
Pertussis
ChartChart
  87  17  16  28  56  13  752  3'083 
Polio*
ChartChart
 
Rubella
ChartChart
  12 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  16  16  15 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Greece)
Vaccine year result method % card seen                                                
BCG          35  35  88 
DTP1          99*  99*  99*  99*  99* 
DTP3          99*  99*  99*  99*  99*  54  72 
DTP4          96  96  96 
IPV1          99*  99*  99* 
HepB_BD         
HepB3          96  96  96  98  98 
Hib3          99  99  99  95  95 
JapEnc         
MCV1          97  97  97  99  99  76 
MCV2          83  83 
MenA         
PCV1          99*  99*  99*  94  94 
PCV2          99  99  99  64  64 
PCV3          96  96  96  32  32 
Pol3          99*  99*  99*  99*  99*  96  90 
Rota1          25  25  25 
RotaC          20  20  20 
RCV1          97  97  97  99 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Greece)
BCG
  86  95 
DTP1
ChartChart
  99  99  99  99  99  96  77  89 
DTP3
ChartChart
  99  99  99  99  99  89  54  72 
HepB3
ChartChart
  96  96  96  98  98  89 
HepB_BD
 
Hib3
ChartChart
  99  99  99  94  94  87 
MCV1
ChartChart
  97  97  97  99  99  89  76 
MCV2
ChartChart
  83  83  83  83  83 
PCV3
ChartChart
  96  96  96  32  32 
Pol3
ChartChart
  99  99  99  99  99  89  96  90 
RCV1
ChartChart
  97  97  97  99  99  89 
RotaC
ChartChart
  20  20  20 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 54  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes from high risk groups
DTaP 2, 4, 6, 15-18 months; 4-6 years; Either DtaP or other combination vaccine
HepA_Adult 19-65 years; Yes for high risk groups
HepA_Pediatric > 12 months; Yes
HepB_Adult >= 19 years; Yes
HepB_Pediatric birth or 2 months; 4, 6 months; Yes
Hib 2, 4, 6, 12-15 months; Yes Administered in various combination types of vaccines
HPV 11-15 years (x2); Yes
Influenza_Adult >= 60 years; Yes and pregnant women, health care workers, adults with chronic diseases, and other risk groups
Influenza_Pediatric Yes chronic diseases and risk groups
IPV 2, 4, 6-18 months; 4-6 years; Yes
MenACWY 11-12 years; Yes
MenC_conj 12 months; Yes
MMR 12-15 months; 4-6 years; Yes
MMRV 12-15 months; 4-6 years; Yes
Pneumo_conj 2, 4, 6, 12-15 months; 2-3, 50 years; Yes for the dose administered at 2-3 years, PCV13 only for children vaccinated with PCV7 or PCV10
Pneumo_ps Yes persons 2-50 years belonging to high risk groups
Rotavirus 2, 4, 6 months; Yes Number of doses depend on vaccine presentation
Td Yes 10 years after TdaP and every 10 years afterwards
Tdap 11-12 years; Yes
TdaPIPV 11-12 years; Yes
TdIPV 11-12 years; Yes
Varicella 12-15 months; 4-6 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR             No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number 54  54  54  54  54  54  54 
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND              
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR              

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.